UNSPSC 41131709: Fibrin monomer paracoagulation test

In this classification a fibrin monomer paracoagulation test is a device used to detect fibrin monomer in the diagnosis of disseminated intravascular coagulation (non localized clotting within a blood vessel) or in the differential diagnosis between disseminated intravascular coagulation and primary fibrinolysis (dissolution of the fibrin in a blood clot) US FDA regulates Fibrin monomer Para coagulation test under 21 CFR 864.7300 and under FDA product code JBM.

UNSPSC 41131709 Fibrin monomer paracoagulation test is a Commodity code, but the recent state and local opportunities tagged under it do not reflect testing for fibrin monomer paracoagulation; instead, they span drug testing, employment screening, breath alcohol measurement, and forensic drug analysis—a significant scope mismatch that makes this code a poor predictor of relevant procurement activity. The solicitations show state and local governments buying pre-employment drug screening (immunoassay and confirmatory testing by LC/MS/MS or GC/MS), urinalysis panels, oral fluid and hair testing, employment physicals bundled with drug testing, breath alcohol devices (Intoxilyzer 9000), and certified reference materials for forensic drug analysis. Issuers include county community supervision and corrections departments (offender monitoring), county human resources divisions (employee screening), county health and forensic laboratories, state departments of public safety, community colleges, and county sheriffs conducting employment vetting. The work spans both service delivery (specimen collection, testing, result reporting) and equipment procurement (breath alcohol analyzers, lab supplies).

Recent activity clusters in Florida, Oregon, Texas, Nevada, and Illinois. The Collin County Community Supervision and Corrections Department issued an RFP on July 9, 2026 (due July 23, 2026) for offender specimen collection and drug testing services covering approximately 25,031 annual tests with an estimated contract value of $600,000 over two years plus three optional one-year renewals. Benton County, Oregon posted an RFP on June 6, 2026 (due July 7, 2026) for urinalysis testing supporting its Family Treatment Court Program, requiring CLIA-certified laboratory services with twice-weekly testing and results within 48–72 hours. Pinellas County, Florida issued an Invitation to Quote on April 23, 2026 for drug standards (certified reference materials) to support forensic toxicology and seized drug analysis, funded through the Paul Coverdell Forensic Sciences Improvement Act Program with approximately $49,034 designated for supplies and equipment. City Colleges of Chicago released RFP #MWJ2603 on February 18, 2026 (due March 30, 2026) for comprehensive employment screening services covering pre-employment drug testing, background investigations, and medical review officer support for approximately 1,500–1,600 candidates annually across a seven-college system, with required MBE and WBE participation goals of 25% and 7% respectively. The Nevada Department of Public Safety posted two separate solicitations in late January 2026 for Intoxilyzer 9000 breath alcohol testing devices and associated printers. The code's abstract definition and actual procurement activity diverge significantly, limiting its utility for targeting vendors in this commodity space.